Schedule-dependent increased efficiency of pemetrexed-ionizing radiation combination therapy elicits a differential DNA damage response in lung cancer cells

BACKGROUND: Lung cancer causes the most cancer deaths worldwide, thus there is a urgent need to develop new treatment options. Concurrent chemoradiotherapy has become a common strategy for the treatment of non-resectable solid tumors including non-small cell lung cancer. Pemetrexed is a folic acid a...

Descripción completa

Detalles Bibliográficos
Autores principales: Dorn, Patrick, Tièche, Colin Charles, Peng, Ren-Wang, Froment, Laurène, Schmid, Ralph Alexander, Marti, Thomas Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Primary Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5010745/
https://www.ncbi.nlm.nih.gov/pubmed/27594806
http://dx.doi.org/10.1186/s12935-016-0346-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5010745/
https://www.ncbi.nlm.nih.gov/pubmed/27594806
http://dx.doi.org/10.1186/s12935-016-0346-x

Ejemplares similares